The global RNA Microarray market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for RNA Microarray is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Microarray is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA Microarray in Research Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA Microarray include Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays, Arrayit, Sengenics, Biometrix Technology and Savyon Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Microarray, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Microarray.
Report Scope
The RNA Microarray market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Microarray market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Microarray companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Segment by Type
Oligonucleotide RNA Microarrays (oRNA)
Complementary RNA Microarrays (cRNA)
Segment by Application
Research Centers
Clinical
Commercial Molecular Diagnostic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Microarray companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global RNA Microarray Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oligonucleotide RNA Microarrays (oRNA)
1.2.3 Complementary RNA Microarrays (cRNA)
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global RNA Microarray Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Centers
1.3.3 Clinical
1.3.4 Commercial Molecular Diagnostic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Microarray Âé¶¹Ô´´ Perspective (2019-2030)
2.2 RNA Microarray Growth Trends by Region
2.2.1 Global RNA Microarray Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNA Microarray Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 RNA Microarray Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 RNA Microarray Âé¶¹Ô´´ Dynamics
2.3.1 RNA Microarray Industry Trends
2.3.2 RNA Microarray Âé¶¹Ô´´ Drivers
2.3.3 RNA Microarray Âé¶¹Ô´´ Challenges
2.3.4 RNA Microarray Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Microarray Players by Revenue
3.1.1 Global Top RNA Microarray Players by Revenue (2019-2024)
3.1.2 Global RNA Microarray Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global RNA Microarray Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Microarray Revenue
3.4 Global RNA Microarray Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global RNA Microarray Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Microarray Revenue in 2023
3.5 RNA Microarray Key Players Head office and Area Served
3.6 Key Players RNA Microarray Product Solution and Service
3.7 Date of Enter into RNA Microarray Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Microarray Breakdown Data by Type
4.1 Global RNA Microarray Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global RNA Microarray Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 RNA Microarray Breakdown Data by Application
5.1 Global RNA Microarray Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global RNA Microarray Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America RNA Microarray Âé¶¹Ô´´ Size (2019-2030)
6.2 North America RNA Microarray Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNA Microarray Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America RNA Microarray Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Microarray Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe RNA Microarray Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNA Microarray Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe RNA Microarray Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Microarray Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific RNA Microarray Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNA Microarray Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific RNA Microarray Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Microarray Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America RNA Microarray Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNA Microarray Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America RNA Microarray Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Microarray Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa RNA Microarray Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNA Microarray Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa RNA Microarray Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumnia
11.1.1 Illumnia Company Detail
11.1.2 Illumnia Business Overview
11.1.3 Illumnia RNA Microarray Introduction
11.1.4 Illumnia Revenue in RNA Microarray Business (2019-2024)
11.1.5 Illumnia Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Detail
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix RNA Microarray Introduction
11.2.4 Affymetrix Revenue in RNA Microarray Business (2019-2024)
11.2.5 Affymetrix Recent Development
11.3 Agilent
11.3.1 Agilent Company Detail
11.3.2 Agilent Business Overview
11.3.3 Agilent RNA Microarray Introduction
11.3.4 Agilent Revenue in RNA Microarray Business (2019-2024)
11.3.5 Agilent Recent Development
11.4 Scienion AG
11.4.1 Scienion AG Company Detail
11.4.2 Scienion AG Business Overview
11.4.3 Scienion AG RNA Microarray Introduction
11.4.4 Scienion AG Revenue in RNA Microarray Business (2019-2024)
11.4.5 Scienion AG Recent Development
11.5 Applied Microarrays
11.5.1 Applied Microarrays Company Detail
11.5.2 Applied Microarrays Business Overview
11.5.3 Applied Microarrays RNA Microarray Introduction
11.5.4 Applied Microarrays Revenue in RNA Microarray Business (2019-2024)
11.5.5 Applied Microarrays Recent Development
11.6 Arrayit
11.6.1 Arrayit Company Detail
11.6.2 Arrayit Business Overview
11.6.3 Arrayit RNA Microarray Introduction
11.6.4 Arrayit Revenue in RNA Microarray Business (2019-2024)
11.6.5 Arrayit Recent Development
11.7 Sengenics
11.7.1 Sengenics Company Detail
11.7.2 Sengenics Business Overview
11.7.3 Sengenics RNA Microarray Introduction
11.7.4 Sengenics Revenue in RNA Microarray Business (2019-2024)
11.7.5 Sengenics Recent Development
11.8 Biometrix Technology
11.8.1 Biometrix Technology Company Detail
11.8.2 Biometrix Technology Business Overview
11.8.3 Biometrix Technology RNA Microarray Introduction
11.8.4 Biometrix Technology Revenue in RNA Microarray Business (2019-2024)
11.8.5 Biometrix Technology Recent Development
11.9 Savyon Diagnostics
11.9.1 Savyon Diagnostics Company Detail
11.9.2 Savyon Diagnostics Business Overview
11.9.3 Savyon Diagnostics RNA Microarray Introduction
11.9.4 Savyon Diagnostics Revenue in RNA Microarray Business (2019-2024)
11.9.5 Savyon Diagnostics Recent Development
11.10 WaferGen
11.10.1 WaferGen Company Detail
11.10.2 WaferGen Business Overview
11.10.3 WaferGen RNA Microarray Introduction
11.10.4 WaferGen Revenue in RNA Microarray Business (2019-2024)
11.10.5 WaferGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Ìý
Ìý
*If Applicable.